Markets · Global Equities · US

AbbVie Inc. ABBV

Exchange NYSE. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.

• Revenue TTM 65.17B
• EBITDA TTM 19.36B
• Net debt 53.70B
• ND/EBITDA 2.77
• EBITDA/interest 6.44
• ROE -1.90
• Implied band BBB

All countries